S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Stock market today: Global markets are mixed as Middle East tensions escalate
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Citi’s Results Say This About The Stock Market

BioLogic Equity Research Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at BioLogic Equity Research. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by BioLogic Equity Research.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
Sangamo Therapeutics, Inc. stock logo
SGMO
Sangamo Therapeutics
$0.54
-0.3%
5/3/2013Initiated byBioLogic Equity Research-SellN/AView details for BioLogic Equity Research rating of Sangamo Therapeutics (NASDAQ:SGMO) on 5/3/2013
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$23.51
-1.3%
1/5/2012Initiated byBioLogic Equity Research-SellN/AView details for BioLogic Equity Research rating of Corcept Therapeutics (NASDAQ:CORT) on 1/5/2012

MarketBeat Community Rating for BioLogic Equity Research

Community Ranking:  2.7 out of 5 (
2.7 of 5 stars)
Outperform Votes:  23,999 (Vote Outperform)
Underperform Votes:  20,722 (Vote Underperform)
Total Votes:  44,721
MarketBeat's community ratings are surveys of what our community members think about BioLogic Equity Research and other research firms. Vote "Outperform" if you believe BioLogic Equity Research's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BioLogic Equity Research's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools